Details for 2010732616
Up to date per 05.04.2026
Actions
Details for 2010732616
Granted/Registered
European Patent
23.05.2012 A
04.11.2015 B1
15.07.2009
US
225803 P
A61K 31/445 20060101AFI20110204BHEP
Owner
Theravance Biopharma R&D IP, LLC901 Gateway Boulevard South San Francisco, CA 94080US
Representative
Representative
Patentanwälte Puchberger & PartnerReichsratsstraße 131010 WienAT
Inventor
WOOLLAM, Grahame85 Tanbridge Park Horsham Sussex RH121SFGB
Information about Fees